Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biobucks
Biotech
Lilly, Haya ink $1B biobuck obesity pact to search dark genome
Lilly has put together a deal worth up to $1 billion in biobucks to partner with Haya to find multiple regulatory-genome-derived RNA-based drug targets.
Nick Paul Taylor
Sep 4, 2024 8:00am
Adcendo signs $1B biobuck deal for Multitude's anti-TF ADC
Aug 20, 2024 7:22am
Merck inks $1.6B-plus exclusive licensing pact with Orion
Jul 1, 2024 10:38am
Ipsen, Marengo ink $1.2B biobuck deal to treat cold tumors
Jun 7, 2024 9:15am
Takeda gets crafty with molecular glue deal worth $1.2B biobucks
May 23, 2024 5:30am
Novo Nordisk pens $600M obesity pact with Flagship's Metaphore
May 9, 2024 7:00am